ArticleHemaSphere2026

Correction to "Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry".

No numbers read from the abstract.

Not cited yet